hotspot -WSS

hotspot

author：leisure time 2025-10-01 04:10:53 - browse：4

Illustration of doctor with an computer text bubble for a face for a story on Chat GPT and AI – health tech coverage from STAT — Mike Reddy for STAT

Health care companies are racing to incorporate generative AI tools into their product pipelines and IT systems after the technology displayed an ability to perform many tasks faster, cheaper — and sometimes better — than humans.

But the rush to harness the power of so-called large language models, which are trained on vast troves of data, is outpacing efforts to assess their value. AI experts are still trying to understand, and explain, how and why they work better than prior systems, and what blind spots might undermine their usefulness in medicine.

It remains unclear, for example, how well these models will perform, and what privacy and ethical quandaries will arise, when they’re exposed to new types of data, such as genetic sequences, CT scans, and electronic health records. Even knowing exactly how much data must be fed into a model to achieve peak performance on a given task is still largely guesswork.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Texas Medical Board asked to define abortion emergency exception

WSS

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Why depression after traumatic brain injury is distinct

Top private equity targets in 2023: cardiology, clinical trials, lasers

President Biden's budget: Here's what you might have missed

AstraZeneca stays mum on Medicare drug pricing negotiations

entertainment

hotspot

knowledge

Duchenne breakthrough therapy leaves behind pioneering families

How many hemophilia patients actually want gene therapy?

As demand for Covid shots wanes, Moderna seeks its next success

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

How to save PrEP access — and even expand it

Updated Covid vaccine has 54% effectiveness, new study suggests

How to save PrEP access — and even expand it

Pushing for an NIH office for post

Dobbs anniversary: the lost opportunity of abortion as health care

A single Democrat is willing to weaken Medicare negotiation power

leisure time

Problems with a popular proposal to regulate AI in health care

Why scientists need input from humanists on sensitive research

The Biogen Aduhelm mess could happen again

Surgery pushed Ben Carson to fame

Why depression after traumatic brain injury is distinct

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

focus

leisure time

explore

hotspot